[HTML][HTML] Seroconversion rates following COVID-19 vaccination among patients with cancer
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
TM Narowski, K Raphel, LE Adams, J Huang, NA Vielot… - Cell reports, 2022 - cell.com
Understanding vaccine-mediated protection against severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 …
coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 …
Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient
JA Hill, CS Ujjani, AL Greninger, M Shadman… - Cancer Cell, 2021 - cell.com
We read with great interest the recent publications in Cancer Cell regarding seroconversion
rates following SARS-CoV-2 vaccination among patients with cancer (Addeo et al., 2021; …
rates following SARS-CoV-2 vaccination among patients with cancer (Addeo et al., 2021; …
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination
It is well established that COVID-19 carries a higher risk of morbidity and mortality in patients
with hematologic malignancies [1, 2]. The mRNA-based vaccines BNT162b2 (Pfizer) and …
with hematologic malignancies [1, 2]. The mRNA-based vaccines BNT162b2 (Pfizer) and …
A Scalar Approach to Vaccination Ethics
Should people get vaccinated for the sake of others? What could ground—and limit—the
normative claim that people ought to do so? In this paper, we propose a reasons-based …
normative claim that people ought to do so? In this paper, we propose a reasons-based …
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal strain-specific neutralizing antibodies in naïve and previously infected …
TM Narowski, K Raphel, LE Adams, J Huang, NA Vielot… - bioRxiv, 2021 - biorxiv.org
With the advance of SARS-CoV-2 vaccines, the outlook for overcoming the global COVID-19
pandemic has improved. However, understanding of immunity and protection offered by the …
pandemic has improved. However, understanding of immunity and protection offered by the …
What did we learn from the SARS-CoV-2 vaccine breakthrough infections
The unprecedented pace in vaccine research and clinical development have provided a
number of COVID-19 vaccines now widely used and many more candidates are currently in …
number of COVID-19 vaccines now widely used and many more candidates are currently in …